Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Practices in Molecular Docking and Structure-Based Virtual Screening
Ricardo Nascimento dos Santos, Leonardo L. G. Ferreira, Adriano D. Andricopulo
Methods in molecular biology (2018), pp. 31-50
Closed Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

Current trends in computer aided drug design and a highlight of drugs discovered via computational techniques: A review
Victor T. Sabe, Thandokuhle Ntombela, Lindiwe A. Jhamba, et al.
European Journal of Medicinal Chemistry (2021) Vol. 224, pp. 113705-113705
Closed Access | Times Cited: 436
Empirical Scoring Functions for Structure-Based Virtual Screening: Applications, Critical Aspects, and Challenges
Isabella Alvim Guedes, Felipe Siconha S. Pereira, Laurent E. Dardenne
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 258
Highly Flexible Ligand Docking: Benchmarking of the DockThor Program on the LEADS-PEP Protein–Peptide Data Set
Karina B. Santos, Isabella Alvim Guedes, Ana L. M. Karl, et al.
Journal of Chemical Information and Modeling (2020) Vol. 60, Iss. 2, pp. 667-683
Closed Access | Times Cited: 219
Artificial intelligence and machine learning approaches for drug design: challenges and opportunities for the pharmaceutical industries
Chandrabose Selvaraj, Ishwar Chandra, Sanjeev Kumar Singh
Molecular Diversity (2021) Vol. 26, Iss. 3, pp. 1893-1913
Open Access | Times Cited: 125
Boosting the Full Potential of PyMOL with Structural Biology Plugins
Serena Rosignoli, Alessandro Paiardini
Biomolecules (2022) Vol. 12, Iss. 12, pp. 1764-1764
Open Access | Times Cited: 100
DockingPie: a consensus docking plugin for PyMOL
Serena Rosignoli, Alessandro Paiardini
Bioinformatics (2022) Vol. 38, Iss. 17, pp. 4233-4234
Open Access | Times Cited: 39
A practical guide to machine-learning scoring for structure-based virtual screening
Viet‐Khoa Tran‐Nguyen, Muhammad Junaid, Saw Simeon, et al.
Nature Protocols (2023) Vol. 18, Iss. 11, pp. 3460-3511
Closed Access | Times Cited: 38
Why hasn’t there been more progress in new Chagas disease drug discovery?
Alane Beatriz Vermelho, Giseli Capaci Rodrigues, Claudiu T. Supuran
Expert Opinion on Drug Discovery (2019) Vol. 15, Iss. 2, pp. 145-158
Closed Access | Times Cited: 66
Beware of Simple Methods for Structure-Based Virtual Screening: The Critical Importance of Broader Comparisons
Viet‐Khoa Tran‐Nguyen, Pedro J. Ballester
Journal of Chemical Information and Modeling (2023) Vol. 63, Iss. 5, pp. 1401-1405
Open Access | Times Cited: 16
Luteolin Inhibits Vascular Smooth Muscle Cell Proliferation and Migration by Inhibiting TGFBR1 Signaling
Yuting Wu, Ling Chen, Zhang‐Bin Tan, et al.
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 54
The impact of compound library size on the performance of scoring functions for structure-based virtual screening
Louison Fresnais, Pedro J. Ballester
Briefings in Bioinformatics (2020) Vol. 22, Iss. 3
Open Access | Times Cited: 42
An Overview of Biological and Computational Methods for Designing Mechanism-Informed Anti-biofilm Agents
Andy Y. An, Ka-Yee Grace Choi, Arjun Baghela, et al.
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 39
Alkaloids from Caliphruria subedentata (Amaryllidaceae) as Regulators of AChE, BuChE, NMDA and GSK3 Activity: An In Vitro and In Silico Approach for Mimicking Alzheimer´s Disease
Willian Orlando Castillo Ordoñez, Nilza Velasco Palomino, Patrícia Varela, et al.
Neurochemical Research (2025) Vol. 50, Iss. 2
Open Access
Of Drugs and Trypanosomatids: New Tools and Knowledge to Reduce Bottlenecks in Drug Discovery
Arijit Bhattacharya, Audrey Corbeil, Rubens Lima do Monte‐Neto, et al.
Genes (2020) Vol. 11, Iss. 7, pp. 722-722
Open Access | Times Cited: 37
Turning high-throughput structural biology into predictive inhibitor design
Kadi L. Saar, William McCorkindale, D. Fearon, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 11
Open Access | Times Cited: 12
Deciphering multifaceted molecular mechanisms of matairesinol in inhibiting triple-negative breast cancer through comprehensive systems biology investigations
Amol Chaudhary, Nidhi Sharma, Amrita Ulhe, et al.
Journal of Biomolecular Structure and Dynamics (2025), pp. 1-26
Closed Access
Assessing multiple score functions in Rosetta for drug discovery
Shannon T. Smith, Jens Meiler
PLoS ONE (2020) Vol. 15, Iss. 10, pp. e0240450-e0240450
Open Access | Times Cited: 26
PEPPSI type complexes: Synthesis, x-ray structures, spectral studies, molecular docking and theoretical investigations
Goncagül Serdaroğlu, Neslihan Şahin, Elvan Üstün, et al.
Polyhedron (2021) Vol. 204, pp. 115281-115281
Closed Access | Times Cited: 23
ClassyPose: A Machine‐Learning Classification Model for Ligand Pose Selection Applied to Virtual Screening in Drug Discovery
Viet‐Khoa Tran‐Nguyen, Anne‐Claude Camproux, Olivier Taboureau
Advanced Intelligent Systems (2024) Vol. 6, Iss. 12
Open Access | Times Cited: 2
Quantum Molecular Docking with a Quantum-Inspired Algorithm
LI Yunting, Xiaopeng Cui, Zhaoping Xiong, et al.
Journal of Chemical Theory and Computation (2024) Vol. 20, Iss. 15, pp. 6687-6694
Open Access | Times Cited: 2
Chemoinformatics Strategies for Leishmaniasis Drug Discovery
Leonardo L. G. Ferreira, Adriano D. Andricopulo
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 21
Molecular docking and molecular dynamic simulation approaches for drug development and repurposing of drugs for severe acute respiratory syndrome-Coronavirus-2
Pattnaik Subhaswaraj, Siddhardha Busi
Elsevier eBooks (2022), pp. 207-246
Closed Access | Times Cited: 10
Bio-inspired optimization for the molecular docking problem: State of the art, recent results and perspectives
María Jesús García-Godoy, Esteban López-Camacho, José García-Nieto, et al.
Applied Soft Computing (2019) Vol. 79, pp. 30-45
Open Access | Times Cited: 17
Cruzain structures: apocruzain and cruzain bound to S-methyl thiomethanesulfonate and implications for drug design
Elany Barbosa da Silva, Elfriede Dall, Peter Briza, et al.
Acta Crystallographica Section F Structural Biology Communications (2019) Vol. 75, Iss. 6, pp. 419-427
Open Access | Times Cited: 16
Structure investigation, enrichment analysis and structure-based repurposing of FDA-approved drugs as inhibitors of BET-BRD4
Padmaja D. Wakchaure, V. Ravichandiran, Kuldeep K. Roy
Journal of Biomolecular Structure and Dynamics (2018) Vol. 37, Iss. 12, pp. 3048-3057
Closed Access | Times Cited: 15
Page 1 - Next Page

Scroll to top